Glycosaminoglycans and Podocyte Behavior in the Renal Glomerulus
Glycosaminoglycans and Podocyte Behavior in the Renal Glomerulus
批准号:
8324714
负责人:
KEVIN John MCCARTHY
金额:
$30.51万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-10 至 2015-06-30
关键词:
AcuteAdhesionsAdultAffectAgeAge-MonthsAlbuminuriaAnimal ModelAnimalsApoptosisBasement membraneBehaviorBindingBlood capillariesCell LineCell ProliferationCell Surface ReceptorsCell membraneCell surfaceCellsChargeChronic DiseaseCicatrixControl AnimalDataDevelopmentDiabetes MellitusDiseaseDystroglycanEXT1 geneEnzymesEventExcisionFibroblastsFiltrationFocal AdhesionsFoot ProcessFunctional disorderGlomerular CapillaryGlycosaminoglycansGlypicanHeparitin SulfateImmunohistochemistryIn VitroIntegrinsInvestigationKidneyKidney DiseasesKidney GlomerulusKnock-outKnockout MiceLaboratoriesLeadMediatingModelingMolecularMorphologyNormal tissue morphologyPatternPerinatal mortality demographicsProcessProtein IsoformsProteinuriaProteoglycanRoleStagingStructureSurfaceSystemTechnologyTestingTimeUltrafiltrationWild Type Mousecapillarycell behaviordensityglomerular functionknockout animallight microscopymembrane synthesismouse modelnovelpodocytepolysulfated glycosaminoglycanprotein expressionproteoglycan core proteinpublic health relevancereceptorslit diaphragmsyndecanyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Previous studies have demonstrated that the heparan sulfate glycosaminoglycans (HS-GAG) have an integral role in the process of glomerular ultrafiltration, showing that removal of HS-GAG compromised the permeaselectivity of the ultrafiltration barrier. Subsequent studies have shown that in diseases, such as diabetes mellitus, the loss of HS-GAG from the glomerular capillary basement membrane (GBM) is associated with the onset of proteinuria and the beginning of prosclerotic changes in the renal glomerulus. Although permeaselectivity of the GBM may be one function of the HS-GAG, data from our laboratory suggests perhaps an even more critical role for GBM HS-GAGs is the control of podocyte behavior. Using Cre-lox technology to selectively delete the EXT1 gene, which encodes for the first enzyme in HS-GAG chain elongation on proteoglycan core proteins, we eliminated the assembly of all HS-GAGs made by podocytes. Conventional wisdom would predict that animals genetically manipulated in this manner should suffer perinatal mortality due to severe, acute proteinuria. However, PEXTKO (Podocyte EXT1 knockout) mice do not develop significant proteinuria. Routine light microscopy studies of young adult PEXTKO animals show no distinct differences in morphology. However at the ultrastructural level, there are significant changes in the glomerulus such as podocyte foot process effacement and enhanced GBM synthesis and turnover. Immunohistochemistry studies indicate that podocytes detach and are lost from the glomeruli of these animals. As the animals age, mild proteinuria does develop. Because of the above data, our hypothesis is that HS-GAGs directly influence podocyte behavior in normal tissues by mediating podocyte-GBM interactions and the loss of these interactions are manifested in diseases that cause the loss of HS-GAG. To test the hypothesis we propose the following specific aims: 1. To investigate the role of HS-GAGs in modulating podocyte-GBM interactions and ultimately glomerular function in developing and adult wild-type mice and PEXTKO mice; 2. Investigate the mechanism by which HS-GAG influences podocyte cell behavior using immortalized EXT1 fl/fl and EXT1 fl/+ podocyte cell lines.
PUBLIC HEALTH RELEVANCE
Diseases,such as diabetes mellitus, have profound effects on the filtration apparatus of the kidney. The primary manifestation of these diseases is gradual scarring of the filtration apparatus of the kidney, which results in dysfunction and eventual demise of the filtration apparatus. Using a novel animal model which manifests several changes seen in renal diseases we will investigate the mechanism by which glomerular cells interact with the filtration surface.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1017/s1431927611012682
发表时间:
2012-02
期刊:
MICROSCOPY AND MICROANALYSIS
影响因子:
2.8
作者:
[McCarthy, Kevin J., Wassenhove-McCarthy, Deborah J.]
通讯作者:
Wassenhove-McCarthy, Deborah J.
DOI:
10.1038/ki.2013.281
发表时间:
2014-02
期刊:
Kidney international
影响因子:
19.6
作者:
[Sugar T, Wassenhove-McCarthy DJ, Esko JD, van Kuppevelt TH, Holzman L, McCarthy KJ]
通讯作者:
McCarthy KJ
N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.
硫酸乙酰肝素的 N-硫酸化对于 syndecan-4 介导的足细胞细胞-基质相互作用至关重要。
DOI:
10.1152/ajprenal.00603.2015
发表时间:
2016
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Sugar,Terrel, Wassenhove-McCarthy,DeborahJ, Orr,AWayne, Green,Jonette, vanKuppevelt,ToinH, McCarthy,KevinJ]
通讯作者:
McCarthy,KevinJ
The role ofglycosaminoglycan N-sulfation in glomerular biology/pathobiology
-
批准号:10188513
-
项目类别:
-
资助金额:$42.87万
-
财政年份:2017
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Glycosaminoglycans and Podocyte Behavior in the Renal Glomerulus
-
批准号:7903830
-
项目类别:
-
资助金额:$15.47万
-
财政年份:2009
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Glycosaminoglycans and Podocyte Behavior in the Renal Glomerulus
-
批准号:8109885
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2008
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Glycosaminoglycans and Podocyte Behavior in the Renal Glomerulus
-
批准号:7653642
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2008
-
负责人:KEVIN John MCCARTHY
-
依托单位:
PROTEOGLYCANS IN DIABETIC NEPHROPATHY
-
批准号:2414872
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
PROTEOGLYCANS IN DIABETIC NEPHROPATHY
-
批准号:2148094
-
项目类别:
-
资助金额:$14.1万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Proteoglycans in Diabetic Nephropathy
-
批准号:6736815
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Proteoglycans in Diabetic Nephropathy
-
批准号:6635019
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Proteoglycans in Diabetic Nephropathy
-
批准号:6846352
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Proteoglycans in Diabetic Nephropathy
-
批准号:6517300
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
Proteoglycans in Diabetic Nephropathy
-
批准号:6328274
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
PROTEOGLYCANS IN DIABETIC NEPHROPATHY
-
批准号:2148096
-
项目类别:
-
资助金额:$14.69万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
PROTEOGLYCANS IN DIABETIC NEPHROPATHY
-
批准号:2148095
-
项目类别:
-
资助金额:$14.79万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
PROTEOGLYCANS IN DIABETIC NEPHROPATHY
-
批准号:2697030
-
项目类别:
-
资助金额:$13.17万
-
财政年份:1994
-
负责人:KEVIN John MCCARTHY
-
依托单位:
海外基金